Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanisms of Opioid-induced Respiratory Depression During Sleep
NCT06854211Phase 1Not yet recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Jul 2026
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of morphine (2 arms), sponsored by Brigham and Women's Hospital. Primary endpoint: Change in ventilation per minute during stable sleep at 6 weeks. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
morphine
Beyond the preview
Go deeper on NCT06854211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06854211.